← All trials
NCT02195440
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2014
- Primary completion
- Mar 1, 2017
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Tokyo Metropolitan Komagome HospitalLead sponsor
- Tokyo Metropolitan Komagome HospitalReponsible party - principal investigator
- Tokyo Metropolitan Komagome HospitalOverall official - principal investigator
- Prism ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.